Survival in bladder and renal cell cancers is familial

Journal of the American Society of Nephrology

Volumn 19, Issue 5, 2008, Pages 985-991

  Ji, Anguang ^a   Försti, Asta ^b   Sundquist, Jan ^a   Lenner, Per ^c   Hemminki, Kari ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SURVIVAL; CHILD PARENT RELATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; FAMILIAL CANCER; FAMILIAL INCIDENCE; FEMALE; GENDER; GEOGRAPHIC DISTRIBUTION; HAZARD RATIO; HERITABILITY; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROGENY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SOCIAL STATUS; SURVIVAL TIME; SWEDEN; BLADDER TUMOR; CAUSE OF DEATH; FACTUAL DATABASE; FAMILY; FAMILY HEALTH; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; KIDNEY CARCINOMA; KIDNEY TUMOR; MIDDLE AGED; MORTALITY; RISK FACTOR;

ADULT; CARCINOMA, RENAL CELL; CAUSE OF DEATH; DATABASES, FACTUAL; FAMILY; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SWEDEN; URINARY BLADDER NEOPLASMS;

EID: 44049103194     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2007070818     Document Type: Article

References (25)

1. Center for Epidemiology: Cancer Incidence in Sweden 2002. Stockholm, The National Board of Health and Welfare, 2004. Available at: http://www. socialstyrelsen.se/NR/rdonlyres/66CB280A-5541-451C-A0FE-71E22D8DDE6C/867/ 20034211.pdf.
2. Eble JN, Sauter G, Epstein JI, Sesterhenn IA: Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. Lyon, IARC, 2004
3. Habuchi T, Marberger M, Droller MJ, Hemstreet GP 3rd, Grossman HB, Schalken JA, Schmitz-Drager BJ, Murphy WM, Bono AV, Goebell P, Getzenberg RH, Hautmann SH, Messing E, Fradet Y, Lokeshwar VB: Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers. Urology 66: 64-74, 2005
4. Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C: Mechanisms of disease: The epidemiology of bladder cancer. Nat Clin Pract Urol 3: 327-340, 2006
5. Lane BR, Kattan MW: Predicting outcomes in renal cell carcinoma. Curr Opin Urol 15: 289-297, 2005
6. Lipworth L, Tarone RE, McLaughlin JK: The epidemiology of renal cell carcinoma. J Urol 176: 2353-2358, 2006
7. Borden LS Jr, Clark PE, Hall MC: Bladder cancer. Curr Opin Oncol 17: 275-280, 2005
8. Plna K, Hemminki K: Familial bladder cancer in the National Swedish Family Cancer Database. J Urol 166: 2129-2133, 2001
9. Czene K, Hemminki K: Kidney cancer in the Swedish Family Cancer Database: Familial risks and second primary malignancies. Kidney Int 61: 1806-1813, 2002
10. Hemminki K, Li X: Age-specific familial risks for renal cell carcinoma with evidence on recessive heritable effects. Kidney Int 65: 2298-2302, 2004
11. Pocock SJ, Clayton TC, Altman DG: Survival plots of time-to-event outcomes in clinical trials: Good practice and pitfalls. Lancet 359: 1686-1689, 2002
12. Hahn WC, Weinberg RA: Rules for making human tumor cells. N Engl J Med 347: 1593-1603, 2002
13. Loktionov A: Common gene polymorphisms, cancer progression and prognosis. Cancer Lett 208: 1-33, 2004
14. Furuta E, Bandyopadhyay S, Iiizumi M, Mohinta S, Zhan R, Watabe K: The role of tumor metastasis suppressors in cancers of breast and prostate. Front Biosci 11: 2845-2860, 2006
15. Hedelin H, Jonsson K, Salomonsson K, Boman H: Screening for bladder tumours in men aged 60-70 years with a bladder tumour marker (UBC) and dipstick-detected haematuria using both white-light and fluorescence cystoscopy. Scand J Urol Nephrol 40: 26-30, 2006
16. Boman H, Hedelin H, Holmang S: Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence. J Urol 167: 80-83, 2002
17. Ozols RF, Herbst RS, Colson YL, Gralow J, Bonner J, Curran WJ Jr, Eisenberg BL, Ganz PA, Kramer BS, Kris MG, Markman M, Mayer RJ, Raghavan D, Reaman GH, Sawaya R, Schilsky RL, Schuchter LM, Sweetenham JW, Vahdat LT, Winn RJ: Clinical cancer advances 2006: Major research advances in cancer treatment, prevention, and screening - A report from the American Society of Clinical Oncology. J Clin Oncol 25: 146-162, 2007
18. Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, Steineck G, Kogevinas M, Real FX, Malats N: Epidemiology of urinary bladder cancer: From tumor development to patient's death. World J Urol 25: 285-295, 2007
19. Nguyen DX, Massague J: Genetic determinants of cancer metastasis. Nat Rev Genet 8: 341-352, 2007
20. Tomlins SA, Mehra R, Rhodes DR, Cao X, Wang L, Dhanasekaran SM, Kalyana-Sundaram S, Wei JT, Rubin MA, Pienta KJ, Shah RB, Chinnaiyan AM: Integrative molecular concept modeling of prostate cancer progression. Nat Genet 39: 41-51, 2007
21. Lindor NM, Greene MH: The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst 90: 1039-1071, 1998
22. Czene K, Hemminki K: Familial papillary renal cell tumors and subsequent cancers: A nationwide epidemiological study from Sweden. J Urol 169: 1271-1275, 2003
23. Hemminki K: Genetic epidemiology: Science and ethics on familial cancers. Acta Oncol 40: 439-444, 2001
24. Hemminki K, Li X, Plna K, Granström C, Vaittinen P: The nation-wide Swedish Family-Cancer Database: Updated structure and familial rates. Acta Oncol 40: 772-777, 2001
25. Hemminki K, Granström C, Sundquist J, Lorenzo Bermejo J: The updated Swedish family-cancer database used to assess familial risks of prostate cancer during rapidly increasing incidence. Heredit Cancer Clin Pract 4: 186-192, 2006